Evolution of the Average Target: Charles River Laboratories International, Inc.

Evolution of the Average Target - Charles River Laboratories International, Inc.

Evolution of the Target Price: Charles River Laboratories International, Inc.

Evolution of the Target Price - Charles River Laboratories International, Inc.

Changes in Analyst Recommendations: Charles River Laboratories International, Inc.

ae1cd6c3b8cf748c48a8bfeebab.em06SXkiOTLH5oHaGk0jmFNYeD1-DPlHL0mlqrpcwCE.LCdjEwlGCAqFnvTsaxJh2z1vL1gTbZMScH767YINhUsXCVcbKkB6dp6lxA~85cab5d39f91bd9615076d9a8e508fb3
11-05 UBS Adjusts Price Target on Charles River Laboratories International to $387 From $357, Maintains Buy Rating MT
11-05 Rothschild & Co Redburn Adjusts Price Target on Charles River Laboratories International to $375 From $318 MT
11-05 RBC Raises Price Target on Charles River Laboratories International to $352 From $322, Keeps Outperform Rating MT
11-05 Deutsche Bank Adjusts Charles River Laboratories International Price Target to $350 From $320, Maintains Buy Rating MT
11-05 Jefferies Adjusts Price Target on Charles River Laboratories International to $385 From $340 MT
10-14 JPMorgan Adjusts Price Target on Charles River Laboratories International to $345 From $310 MT
10-12 Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $340 From $300 MT
09-30 UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175 MT
09-28 Jefferies Adjusts PT on Charles River Laboratories International to $340 From $305, Maintains Buy Rating MT
09-25 Charles River Laboratories's DAS Segment Faces Largest Margin Upside, RBC Says MT
09-25 Deutsche Bank Raises Price Target on Charles River Laboratories International to $320 From $300, Keeps Buy Rating MT
09-25 RBC Raises Price Target on Charles River Laboratories International to $322 From $282, Keeps Outperform Rating MT
09-25 Evercore ISI Adjusts PT on Charles River Laboratories International to $330 From $320, Maintains Outperform Rating MT
09-25 Mizuho Adjusts PT on Charles River Laboratories International to $295 From $264, Keeps Neutral Rating MT
09-25 Barclays Adjusts PT on Charles River Laboratories International to $330 From $300, Keeps Overweight Rating MT
09-25 TD Cowen Adjusts PT on Charles River Laboratories International to $325 From $300, Maintains Buy Rating MT
09-25 Baird Adjusts PT on Charles River Laboratories International to $334 From $291, Keeps Outperform Rating MT
09-17 Argus Research Adjusts Charles River Laboratories International PT to $330 From $250, Maintains Buy Rating MT
09-11 Evercore ISI Adjusts PT on Charles River Laboratories International to $320 From $300, Maintains Outperform Rating MT
08-10 TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating MT
08-10 Rothschild & Co Redburn Adjusts PT on Charles River Laboratories International to $318 From $241, Maintains Buy Rating MT
08-06 Barclays Adjusts Price Target on Charles River Laboratories International to $300 From $220 MT
08-06 RBC Adjusts PT on Charles River Laboratories International to $282 From $215, Keeps Outperform Rating MT
08-06 Deutsche Bank Adjusts Charles River Laboratories International PT to $300 From $260, Maintains Buy Rating MT
08-06 Analyst recommendations: AppLovin, Emerson Electric, Roblox, Flutter Entertainment, HubSpot... Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-1.18%
+37.65%
+23.18%
+7.56%
+7.52%
+14.74%
+35.98%
+29.79%
+13.61%
+69.73%
Average +23.86%
Weighted average by Cap. +23.62%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
337.52USD
Average target price
333.53USD
Spread / Average Target
-1.18%
High Price Target
390.00USD
Spread / Highest target
+15.55%
Low Price Target
145.00USD
Spread / Lowest Target
-57.04%

Analyst Consensus Detail

Analyst consensus - Charles River Laboratories International, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Charles River Laboratories International, Inc.
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Charles River Laboratories International, Inc.
  1. Stock Market
  2. Stocks
  3. CRL Stock
  4. Consensus Charles River Laboratories International, Inc.